Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Should Prolonged Infusion of β-Lactams Become Standard of Practice?

Literature DB >> 28487584

Should Prolonged Infusion of β-Lactams Become Standard of Practice?

Abstract

Entities: Chemical

Year: 2017 PMID： 28487584 PMCID： PMC5407426 DOI： 10.4212/cjhp.v70i2.1650

Source DB: PubMed Journal: Can J Hosp Pharm ISSN： 0008-4123

× No keyword cloud information.

36 in total

1. Development and implementation of a piperacillin-tazobactam extended infusion guideline.

Authors: Lynley S Heinrich; Sheri Tokumaru; Nina M Clark; John Garofalo; Jamie L Paek; Shellee A Grim
Journal: J Pharm Pract Date: 2011-12

Review 2. Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.

Authors: Mordechai Grupper; Joseph L Kuti; David P Nicolau
Journal: Clin Microbiol Rev Date: 2016-10 Impact factor: 26.132

3. Clinical and Economic Impact of Empirical Extended-Infusion Piperacillin-Tazobactam in a Community Medical Center.

Authors: Luigi Brunetti; Shirin Poustchi; Daniel Cunningham; Michael Toscani; Joanne Nguyen; Jeremy Lim; Yilun Ding; Ronald G Nahass
Journal: Ann Pharmacother Date: 2015-04-08 Impact factor: 3.154

4. Clinical Outcomes of Extended Versus Intermittent Infusion of Piperacillin/Tazobactam in Critically Ill Patients: A Prospective Clinical Trial.

Authors: Sheung-Yin Fan; Hoi-Ping Shum; Wing-Yee Cheng; Yat-Hei Chan; Sik-Yin McShirley Leung; Wing-Wa Yan
Journal: Pharmacotherapy Date: 2017-01-06 Impact factor: 4.705

5. Empiric treatment of multidrug-resistant Burkholderia cepacia lung exacerbation in a patient with cystic fibrosis: application of pharmacodynamic concepts to meropenem therapy.

Authors: Joseph L Kuti; Kerry M Moss; David P Nicolau; R Frederic Knauft
Journal: Pharmacotherapy Date: 2004-11 Impact factor: 4.705

6. A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.

Authors: Joel M Dulhunty; Jason A Roberts; Joshua S Davis; Steven A R Webb; Rinaldo Bellomo; Charles Gomersall; Charudatt Shirwadkar; Glenn M Eastwood; John Myburgh; David L Paterson; Therese Starr; Sanjoy K Paul; Jeffrey Lipman
Journal: Am J Respir Crit Care Med Date: 2015-12-01 Impact factor: 21.405

Review 7. Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis.

Authors: Matthew E Falagas; Giannoula S Tansarli; Kazuro Ikawa; Konstantinos Z Vardakas
Journal: Clin Infect Dis Date: 2012-10-16 Impact factor: 9.079

Should Prolonged Infusion of β-Lactams Become Standard of Practice?

1. Development and implementation of a piperacillin-tazobactam extended infusion guideline.

Review 2. Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.

3. Clinical and Economic Impact of Empirical Extended-Infusion Piperacillin-Tazobactam in a Community Medical Center.

4. Clinical Outcomes of Extended Versus Intermittent Infusion of Piperacillin/Tazobactam in Critically Ill Patients: A Prospective Clinical Trial.

5. Empiric treatment of multidrug-resistant Burkholderia cepacia lung exacerbation in a patient with cystic fibrosis: application of pharmacodynamic concepts to meropenem therapy.

6. A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.

Review 7. Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis.

8. Pharmacodynamic profiling of antimicrobials against Gram-negative respiratory isolates from Canadian hospitals.

Review 9. Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections.

10. Prolonged versus Intermittent Infusion of β-Lactams for the Treatment of Nosocomial Pneumonia: A Meta-Analysis.

1. Differential antibiotic dosing in critical care: survey on nurses' knowledge, perceptions and experience.